DSM invests in biomaterials company Oxford Performance Materials
22-Jun-2006
OPM markets biocompatible high performance polymers for use in medical device applications such as catheters and implantable devices. OPM's polymers offer advantages over metals in terms of improved biocompatibility, process flexibility, radiolucense and tailored formulations to meet biomechanical and design criteria.
Most read news
Topics
DSM
polymers
Oxford Performance Materials
medical devices
catheters
Ohira-Bestmann Reagent
Reissert Compound
Organizations
DSM
Oxford Performance Materials
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.